CSIMarket Company Name, Ticker, Industry, else..
 
Balchem Corp  (NASDAQ: BCPC)
 
Price: $175.8900 $-2.55 -1.429%
Day's High: $178.27000427246094 Week Perf: -2.01 %
Day's Low: $ 174.83 30 Day Perf: 4.97 %
Volume (M): 198,243 52 Wk High: $ 183.90
Volume (M$): $ 0 52 Wk Avg: $163.55
Open: $178.20 52 Wk Low: $139.17



 Market Capitalization (Millions $) 5,664
 Shares Outstanding (Millions) 32
 Employees 1,352
 Revenues (TTM) (Millions $) 1,086
 Net Income (TTM) (Millions $) 164
 Cash Flow (TTM) (Millions $) 7
 Capital Exp. (TTM) (Millions $) 37

Business Description


Balchem Corporation, incorporated in the State of Maryland in 1967, is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. Our reportable segments are strategic businesses that offer products and services to different markets. We presently have four reportable segments: Human Nutrition & Health (formerly SensoryEffects); Animal Nutrition & Health; Specialty Products; and Industrial Products.


   Company Address: 5 Paragon Drive Zagreb 7645 City of Zagreb
   Company Phone Number: 326-5600   Stock Exchange / Ticker: NASDAQ BCPC


Customers Net Income grew by BCPC's Customers Net Profit Margin grew to

26.12 %
8.38 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DD   -1.52%    
JNJ   -2.63%    
PFE        1.75% 
• View Complete Report
   



Dividend

Balchem Corporation Surges Ahead with Increased Dividend and Promising Stock Performance

Published Tue, Dec 5 2023 9:15 PM UTC



MONTVALE, N.J., Dec. 05, 2023 - Balchem Corporation (NASDAQ: BCPC) has recently made an exciting announcement regarding its dividend. On December 4, 2023, the company s Board of Directors declared a dividend on its shares of common stock, raising it to $0.79 per share. This represents an 11.3% increase from the previous year s annual dividend. Coupled with recent s...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 34.62
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 5.22
Price to Sales (Expected) -
Price to Book 4.35
PEG (TTM) 2.1

Financial Strength Current
Quick Ratio 0.43
Working Capital Ratio 2.66
Leverage Ratio (MRQ) 0.3
Total Debt to Equity 0.13
Interest Coverage (TTM) 57.04
Debt Coverage (TTM) 1.51

Per Share Current
Earnings (TTM) 5.08 $
Revenues (TTM) 33.72 $
Cash Flow (TTM) 0.23 $
Cash 1.96 $
Book Value 40.45 $
Dividend (TTM) 1.91 $

Efficiency Current
Revenue per Employee (TTM) 803,166
Net Income per Employee (TTM) 121,608
Receivable Turnover Ratio (TTM) 7.51
Inventory Turnover Ratio (TTM) 4.84
Asset Turnover Ratio (TTM) 0.63

Profitability Ratios Current
Gross Margin (MRQ) 36.51 %
Operating Margin (MRQ) 20.85 %
Net Margin (MRQ) 15.71 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 22.59 %

Management Effectiveness Current
Return On Assets (TTM) 9.5 %
Return On Investment (TTM) 10.73 %
Return On Equity (TTM) 12.79 %
Dividend Yield 1.09 %
Pay out Ratio (TTM) 37.6 %



Balchem's Segments
Human Nutrition and Health    122.72 % of total Revenue
Animal Nutrition and Health    44.59 % of total Revenue
Specialty Products    26.49 % of total Revenue
Segment Reporting, Reconciling Item, Corporate Nonsegment    1.52 % of total Revenue
Product Sales    194.92 % of total Revenue
Royalty    0.4 % of total Revenue
United States    141.75 % of total Revenue
Non-US    53.57 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.